Introduction
The human immunodeficiency virus type 1 (HIV-1) epidemic in sub-Saharan Africa has raised concerns that past gains in child survival are being slowed or even reversed [1] [2] [3] [4] . Improvements in child survival have resulted from a variety of interventions [5] , one of the most important of which is childhood immunization. Immunizations are particularly important for HIV-1-infected children as they are at increased risk of severe disease and death from several vaccinepreventable diseases. While there is concern that HIV-1-infected children may have diminished immune responses or experience more frequent adverse events following immunization, in most settings the benefits of immunization far outweigh the risks [6] .
Studies conducted in the United States have not found an association between maternal or child HIV-1 infection and incomplete immunization [7, 8] . These studies, however, were conducted in populations with relatively low HIV-1 prevalence rates and better access to health services compared to those in much of sub-Saharan Africa. Outside the United States, research on the impact of the HIV-1 epidemic on childhood immunization coverage is sparse. In a perinatal HIV-1 intervention trial in Malawi, the proportion of children who received the third dose of diphtheria-tetanus-pertussis vaccine (DTP) was significantly lower among HIV-1-infected than uninfected children [9] .
In Zambia, a complete series of vaccination consists of receipt of a single dose of the Bacille Calmette-Guerin (BCG) vaccine at birth, four doses of the oral polio vaccine (OPV) at 0, 6, 10 and 14 weeks, three doses of the DTP vaccine at 6, 10 and 14 weeks, and measles vaccine at 9 months. We conducted a nested case-control study to assess whether HIV-1 infection was a risk factor for incomplete immunization in hospitalized children with measles in Lusaka, Zambia.
Methods
Child immunization status was assessed within a prospective study of measles in Zambia [10] . The cohort comprised 652 children hospitalized with the clinical diagnosis of measles at the University Teaching Hospital, Lusaka, who were enrolled between January 1998 and October 2000. Those who were severely ill or who died within hours of admission were unlikely to be enrolled. After enrolment, a study nurse or clinical officer administered a questionnaire and performed a physical examination. Information obtained from the parent or guardian included the age and sex of the child, the number of years of education completed by the child's mother and the number of children living in the home. Information on immunizations received by the child was abstracted from the immunization card if available. In the absence of an immunization card, the mother or caretaker was asked a series of questions to recall the immunizations received by the child. For example, mothers were asked how many times the child had received vaccines in the thigh to assess receipt of DTP (since BCG and measles vaccines are given in the arm). With parental consent, blood was taken from each child for laboratory confirmation of measles infection and determination of the child's HIV-1 infection status.
Plasma was tested for antibodies to HIV-1 by enzyme immunoassay (Organon Teknika). Samples positive for HIV-1 were assayed for HIV-1 RNA using a reverse-transcriptase-PCR assay (Amplicor HIV-1 Monitor version 1.5; Roche Molecular Systems). A child was classified as HIV-1 infected if HIV-1 RNA was detected in plasma. Parents could elect to be informed of the HIV-1 infection status of their child after voluntary counselling; however, most parents did not ask for the results of HIV-1 testing.
Children eligible for analysis of immunization status were between the ages of 4 and 60 months, and had information available on immunizations and HIV-1 infection. Four months was selected as the minimum age to allow a 2 week grace period for delayed immunization as many children are not vaccinated according to schedule. To reduce selection bias in this cohort of children hospitalized with measles, measles vaccination status was not used to determine the completeness of immunization.
Children were categorized as completely or incompletely immunized depending upon whether they had received BCG and completed the series of DTP and OPV vaccines. Because measles vaccination status may be associated with HIV-1 infection in this cohort of children with measles (vaccinated HIV-1-infected children may be more likely to have vaccine failure and be hospitalized with measles) and measles vaccination status is likely associated with receipt of DTP3/OPV3, measles vaccination was included as a potential confounder in the logistic regression models.
Information obtained from the immunization record cards and the immunization histories provided by the mother were combined. Logistic regression was used to estimate the unadjusted and adjusted odds ratios of incomplete immunization for the predictor variables. Independent variables assessed in the model were child's age, sex, measles vaccination status and HIV-1 infection status. Because information on the number of years of maternal education and the number of children in the household was available for a smaller subset of children, a second logistic regression analysis was conducted including these children. The number of years of formal education received by the child's mother was categorized as 57 years, 7 years, and 47 years. The number of children in the household (including the index child with measles) was categorized as one to three, four to five, and six or more. Continuous variables were compared using the non-parametric Wilcoxon rank sum test. Statistical analyses were performed using Stata Statistical Software: Release 7.0 (Stata Corporation, College Station, TX).
Results
Children with missing information on immunizations (n ¼ 14) or HIV-1 infection status (n ¼ 11), and children less than 4 months of age (n ¼ 10) or greater than 60 months of age (n ¼ 137), were excluded from analysis. Children excluded because of missing information on immunization status, or because they were outside the study age group, did not differ significantly by HIV-1 infection status from those included in the analysis (data not shown). Seven children aged 9 months or older (2 who were HIV-infected) had missing information on measles vaccination status and also were excluded.
Of the 473 remaining children whose immunization status was determined from the immunization record or maternal recall, 23% were incompletely immunized. Ninety-nine percent of the children received BCG vaccine, and 79% and 81% received DTP3 and OPV3, respectively. Measles vaccine coverage among children who were at least 9 months old was 59%. Nineteen percent of children were HIV-1-infected, and 53% were boys. The age of the HIV-1-infected children (median 10 months; IQR 7, 26) did not differ significantly from the age of HIV-1-uninfected
The proportion of HIV-1-infected children who were incompletely immunized was 32%, compared to only 21% of the uninfected children. The unadjusted odds of incomplete immunization among HIV-1-infected children was almost twice that of uninfected children (OR 1.8; 95% CI 1.1, 3.0) ( Table 1) . After adjusting for age, sex, and measles vaccination status, HIV-1 infection remained significantly associated with incomplete immunization (adjusted OR 1.9; 95% CI 1.1, 3.3). As expected, failure to receive measles vaccination was significantly associated with incomplete immunization with BCG, DPT3 and OPV3 (adjusted OR 8.8; 95% CI 4.1, 18.9) ( Table 1) .
In the subset analysis that included only the 372 children for whom information was available on maternal education and the number of children in the household, the adjusted odds of incomplete immunization was almost four times higher in children whose mothers had less than seven years of formal education compared to children whose mothers had more than seven years of formal education (adjusted OR 3.7; 95% CI 1.8. 7.5) ( Table 1) . The adjusted odds of incomplete immunization was two-three times as high for children who lived in homes with more than 3 children compared to children from homes with 1 to 3 children (Table 1) . Although the adjusted OR for incomplete immunization was little changed for HIV-1-infected children in the subset analysis, the results were not statistically significant because of the loss of power associated with the smaller sample size.
To avoid potential bias introduced by the fact that mothers of HIV-1-nfected children may be deceased and their caretakers less likely to accurately provide the child's immunization history, the analysis was repeated with the 441 children brought to the hospital by their mother (data not tabulated). The results were unchanged, the adjusted odds of incomplete immunization for HIV-1-infected children being 1.9 (95% CI 1.1, 3.4). Within the cohort of 473 children, 25 children were HIV-1 seropositive but HIV-1 uninfected (undetectable HIV-1 RNA), representing HIV-1-uninfected children born to HIV-1-infected women. The median age of these children was 8 months (IQR 7, 8) , consistent with the fact that these children can be identified by laboratory markers only in infancy. Only 16% of these HIV-1-uninfected children born to HIV-1-infected mothers were incompletely immunized.
Discussion HIV-1-infected children were almost twice as likely to be incompletely immunized as uninfected children, despite the fact that the World Health Organization recommends routine childhood immunization for HIV-1-infected children [6] . The only exceptions are recommendations to withhold BCG and yellow fever vaccines from symptomatic HIV-1-infected children. In Africa, over 50% of HIV-1-infected children die by two years of age in the absence of antiretroviral therapy [11] , and vaccine-preventable diseases contribute to the morbidity and mortality [12] . However, few studies have investigated the association between HIV-1 infection and immunization status, particularly in regions of high HIV-1 prevalence.
Although we were unable to explore the reasons for incomplete immunization, the care of HIV-1-infected (and uninfected) children could be adversely affected when their parents develop the acquired immunodeficiency syndrome (AIDS) and are unable to take their children for routine health care and immunizations [13] . Other factors that could contribute to incomplete immunization of HIV-1-infected children include debilitating illness in the child and the mistaken belief that immunizations are not effective in HIV-1-infected children. However, the odds of incomplete immunization remained almost twice as high for HIV-1-infected children compared to uninfected children when the analysis was restricted to children brought to hospital by their mothers, suggesting that maternal mortality or severe maternal illness was not a major contributing factor to incomplete immunization. Few mothers of children in this study elected to be informed of their child's HIV-1 infection status, and there was no routine HIV-1 testing of infants in Zambia at the time, making it less likely that incomplete immunization of HIV-1-infected children was intentional. Although the number of HIV-1-uninfected children born to HIV-1-infected women within the cohort was small, the lower proportion of these children who were incompletely immunized suggests that factors related to the child rather than maternal factors may determine the risk for incomplete immunization. Children with HIV-1 infection are more likely to have frequent illnesses, and to be malnourished, than children without HIV-1 infection.
Missed opportunities to vaccinate children who had symptoms of illness on their scheduled vaccination date could have contributed to the difference in coverage [14] . However, the factors leading to incomplete immunization of HIV-1 infected children require further investigation.
Higher levels of maternal education and smaller family size were associated with complete immunization in this cohort of Zambian children. Prior studies of childhood immunization in sub-Saharan Africa also have found higher levels of maternal education to be predictive of completion of the DTP/OPV series [15] [16] [17] [18] , including a previous study in Lusaka [19] . In countries with low maternal educational levels, teaching mothers the benefits of immunization should be encouraged as a means of improving immunization coverage. We found no differences in immunization status between boys and girls, in contrast to a previous study in Lusaka in which lower immunization rates were observed in girls [19] .
Family size has been used as a measure of socioeconomic status and is associated with immunization status. In Ghana, smaller family size was associated with completion of the immunization series by one year of age [20] . Delayed immunization was associated with larger family size in India [21] , and vaccination against pertussis was less likely in families in the United Kingdom with five or more children [22] . Larger family size would also increase transmission of childhood infections. Family size may be used to identify children at greater risk of vaccine-preventable diseases for targeted interventions to increase vaccine coverage.
Our findings support the hypothesis that HIV-1-infected children are at risk of incomplete immunization compared to uninfected children. In regions of high HIV-1 prevalence, efforts should be made to support HIV-1-infected women in obtaining routine childhood immunizations for their children. This can readily be accomplished within programs providing antiretroviral therapy to prevent maternal-infant transmission of HIV-1 and to treat HIV-1-infected mothers and children. The potential contribution of missed opportunities to vaccinate sick children should be studied and appropriate education of health care providers should be provided to reduce missed opportunities. The strong association between maternal education and childhood immunizations provides further evidence that education of girls can be an important strategy to improve immunization coverage and child health.
